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Suinnlary 
The major histocompatibility complex (MHC)-encoded heterodimeric TAP1/TAP2 transporter 
(TAP) translocates cytosolic peptides into the lumen of the endoplasmic reticulum (ER), where 
peptides of 8 to 11 amino acids long associate with MHC class I molecules. We have studied 
the  selectivity of peptide  translocation by TAP  in  streptolysin O-permeabilized cells using 
glycosylatable, radioiodinated model peptides to detect import into the ER lumen. TAP-dependent 
translocation of a radiolabeled nonamer peptide was most  efficiently inhibited by unlabeled 
9- to 11-mer peptides. Peptides between 7 and 40 amino acids long all could inhibit transport, 
the longer peptides being least  effective.  Also,  peptides shorter than eight amino acids were 
inefficiently translocated. The use of directly labeled length variants in translocation assays and 
TIC analysis of the transported material revealed two pathways for translocation: short peptides 
(7 to 13 amino acids long) were translocated without prior modification. In contrast, transport 
of longer peptides was not effective. Instead such peptides were clipped by cytosolic peptidases 
before efficient transport.  Our  data  suggest  that  TAP preferentially translocates peptides  of 
appropriate length for class I binding. Furthermore, TAP-translocated peptides were rapidly released 
from the ER unless they were trapped there by being glycosylated or by binding to MHC class 
I molecules. 
M 
HC class I molecules present peptides derived from nu- 
clear or cytosolic proteins to CD8 + cytotoxic T cells. 
Naturally processed class I-bound peptides usually have a 
length of 8-11  amino acids (1) and are an integral part of 
the structure of MHC class I molecules (2, 3). Class I mole- 
cules associate with peptide in the lumen of the endoplasmic 
reticulum (ER) 1 (4-6).  Because most of these peptides are 
generated from cytosolic or nuclear proteins, this implies that 
the peptides have to be translocated over the ER membrane. 
The characterization of mutant cell lines expressing "unstable" 
class I molecules unless loaded with exogenous peptides led 
to the characterization of two genes that are required for proper 
peptide loading of class I molecules (7-13). The gene prod- 
ucts were named TAP1 and TAP2 for Transporters Associated 
with Antigen Presentation. Both TAP1 and TAP2 are mul- 
timembrane spanning proteins with an ATP-binding cassette 
and are associated with one another in the ER membrane 
(14,  15). We recently showed that TAP1/TAP2 complexes 
1 Abbreviations used in thispaper: Endo H, endoglycosidase  H; ER, endo- 
plasmic reticulum;  glc, glucose;  HK, hexokinase;  TAP, transporter  associated 
with antigen presentation. 
(TAP) translocates peptides into the ER and that this process 
requires the hydrolysis of ATP (16). 
Proteolytic processing of cytosolic and nuclear proteins pre- 
cedes the translocation of peptides by TAP. This process is 
still ill defined. The cytosolic multicatalytic proteinases (pro- 
teasome) may be involved in this degradation process (17), 
but the evidence is still circumstantial. Introduction of an- 
tigen into the ubiquitin-dependent degradation system (the 
26S form of the proteasome) increased the efficiency of an- 
tigen presentation (18).  Temperature-sensitive mutant cells 
defective in ubiquitin-dependent proteolysis only presented 
antigen efficiently when cultured at the permissive tempera- 
ture (19). Interestingly, the TAP genes are closely located to 
two genes encoding the Lmp2 and Lmp7 subunits of the 
multicatalytic proteasome (20-23).  Although this initially 
suggested the involvement of the proteasome in the genera- 
tion of presentable peptides, transfection studies have shown 
that these proteasome subunits are not essential for antigen 
presentation  (24,  25).  Involvement of other  cytosolic or 
membrane-bound proteases in antigen presentation has not 
been shown, but neither has it been excluded. The processes 
that follow the generation of antigenic fragments in the cytosol 
are unclear. TAP translocates peptides into the lumen of the 
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is not known. Furthermore, it is unclear what the fate of 
the peptides in the ER lumen is. 
We have reconstituted TAP-dependent  translocation of  pep- 
tides into the lumen of the ER in streptolysin O-permeabilized 
cells (16). Here we show that model peptides of 9-11 amino 
acids long are transported most efficiently  and that the affinity 
of longer peptides decreases with increasing size. We found 
longer peptides (16 or more amino acids) not to be trans- 
ported efficiently unless first truncated to shorter peptides. 
Also, peptides that were somewhat longer (12-13 amino acids) 
or shorter (7 amino acids) than the naturally class 1-associated 
peptides were translocated. Once the peptides have arrived 
in the ER lumen, they are rapidly released (unless  they as- 
sociate with ER accessory  molecules or class I molecules). 
Thus, TAP selects for peptide lengths that cover the size of 
peptides found associated with class I molecules. Because pep- 
tides are only transiently present in the ER lumen, class I 
molecules have to bind these peptides with high affinity. 
Materials  and Methods 
Cell Lines.  The following  ceLl  lines  were used: the TAP-deficient 
mutant TxB cell hybrid T2 (28); the parental human B-lympho- 
blastoid cell line ICL 721, and T2 cells transfected with rat TAP1 
and TAP2  a (T2/TAPI+2;  see reference 24). Cells were maintained 
in RPMI 1640 supplemented with 10% FCS. 
Peptides.  The following peptides were used: 
Code  Sequence 
1.  #49  NATY 
2.  #50  ANATY 
3.  #53  RYWANATY 
4.  #54  TRYWANATY 
5.  #55  RYWANATRSA 
6.  #72  RYWANATRSY 
7.  #78  KTWANATRSYE 
8.  #146  VDNKTAY 
9.  #147  TVDNKTRAY 
10.  #148  ETVDNKTFRAY 
11.  #149  I ETVDNKTSFRAY 
12.  #150  Q I ETVDNKTPSFRAY 
13.  #88  [ GS ] 2SRYWANATRSGG 
14.  #89  [ GS ] 4SRYWANATRSGG 
15.  #90  [ GS ] 14SRYWANATRSGG 
16.  SN11  RYWANATRSGG 
17.  SN12A1  AYWANATRSG 
18.  SN12-  YWANATRSG 
Peptides 1-14 were synthesized by f-moc peptide chemistry using 
a AMS 422 Multiple Peptide Synthesizer (ABIMED, Langenfeld, 
Germany) and peptides 15 and 16 were synthesized by t-boc chem- 
istry on a peptide synthesizer (SAM2; Biosearch, a division of Mil- 
lipore Corp., Bedford, MA). Peptides 1-4 and 13-16 were synthe- 
sized with an  amidated COOH  terminus.  The  peptides were 
analyzed by HPIC and TLC and were >95%  pure. 
10 #g peptide was radiolabeled  at unique Tyr residues using chlo- 
famine T-catalyzed iodination (29) and free iodine was removed 
by anion exchange  chromatography  (DOWEX[OH-]).  The specific 
activity of the iodinated peptides ranged from 20-50 #Ci//~g. The 
iodinated peptides were stored at  -20~ 
Peptide Translocation.  Peptide  translocation  was performed as de- 
scribed (16). Briefly,  2.5-5  x  106 cells/incubation were harvested 
and washed once with incubation buffer (130 mM KC1, 10 mM 
NaC1, 1 mM CaCI2, 2 mM EGTA, 2 mM MgC12, 5 mM Hepes, 
pH 7.3). Cells were permeabilized with 2 IU streptolysin O/ml 
(WeUcome Reagent Ltd., Beckenham, UK) in 50 #1 incubation 
buffer for 10 min at 37~  followed by the addition of 10 #1 100 
mM ATP (Boehringer), 10-20 #1 radioiodinated peptide and addi- 
tional incubation buffer to a final volume of 100/~1. Peptide trans- 
location was inhibited by lysing the permeabilized cells with 1 ml 
NP-40 lysis mix. Nuclei were removed and the glycosylated  pep- 
tides were recovered with Con A-Sepharose (Pharmacia, Uppsala, 
Sweden), as described (16). 
In competition  experiments 2.5  x  106  T2/TAP-I+2  cells/ 
sample were permeabilized for 10 min at 37~  with streptolysin 
O, as described (16). Cytosol and nonbound streptolysin O were 
removed by washing the cells three times with PBS supplemented 
with 100 #M glucose, 1 mM MgC12, 1 mM CaC12, and I mg/ml 
BSA. Cells  were then distributed  over tubes containing 100 ng radio- 
iodinated peptide #147 (*2/~Ci), the different concentrations of 
competitor and 10 mM ATP (pH 7). The final volume was 100 
#1. The samples were incubated for 5 rain at 37~  followed by 
lysis, recovery  of the glycosylated  radiolabeled  peptide #147 by Con 
A-Sepharose and quantitation by gamma counting. 
The degradation  of  input peptides was followed  by injecting 2-#1 
samples of the above described reaction mixture (i.e., permeabi- 
lized cells, ATE and input peptide) at different times into 20/zl 
TLC buffer, 10-#1 samples were analyzed by TLC. ATP depletion 
was used to terminate peptide translocation. This was achieved  by 
adding 0.2/xl 1,500 U/ml hexokinase (Boehringer) and 10/~12 M 
glucose to the reaction mixture. The fate of nonglycosylated  pep- 
tides in the ER was followed after inhibition of N-linked glycosy- 
lation by culturing the cells  in the presence of 10/~g/ml tunicamycin 
(Sigma Chemical Co., St. Louis, MO) for 45 min before permea- 
bilization with streptolysin O. The permeabilized cells were in- 
cubated with peptide #88 in the presence of 10 mM ATP for different 
periods, followed by five washes with PBS at 0~  The cells were 
then extracted with 100 #1 phenol and the peptides retained in the 
phenol phase were quantitated by gamma counting. 20 #1 of the 
phenol phase (that contained most peptides) was analyzed  by TIC. 
TLC plates were exposed to Kodak XAR 5 film. 
Gel Electrolahoresis  and Peptide Analysis.  Tricine  SDS-PAGE was 
performed as described (30). After electrophoresis, the gel was im- 
mediately frozen and exposed to Kodak XAR-5 film. TIC was 
performed  on silica-gel  plates (Kieselge160; Merck  Sharpe & Dohme, 
St. Louis,  MO) in n-butanol/pyriffme/acetic add/water (97:75:15:60:) 
followed  by autoradiography. Glycosylated  peptides were analyzed 
on TLC after removal of the N-linked glycan (except for the Ash- 
linked GlcYAc) with endoglycosidase  H (Endo H). The glycosylated 
peptides were first released from the Con A-Sepharose by boiling 
for 10 min in 0.1% SDS. Released peptides were then incubated 
overnight at 37~  in 50 #1 20 mM Na-citrate buffer, pH 5.2, in- 
cluding 2 mU Endo H (Boehringer  GmbH, Mannheim, Germany). 
The size of the translocated peptides was determined by Edman 
degradation using a sequencer (model A75A; Applied Biosystems, 
Foster City, CA), followed  by gamma counting of the amino acids 
released after every Edman degradation step. 
Results 
Translocation of Peptides of Different Lengths by TAP..  Trans- 
location of peptides from the cytosol to the lumen of the 
ER. by TAP was studied as described (16). Iodinated peptides 
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Figure  1.  TAP-dependent  peptide translocation of input peptides of 
different length. Peptides of different size were translocated for 20 min 
in the presence of ATP by streptolysin  O-permeabilized T2 cells trans- 
fected with rat TAP1+2' (T2/TAPI+2) (black bars)  and, as a control, T2 
cells (open bars)  as indicated.  Translocated  peptides  were  isolated  with Con 
A-Sepharose, quantitated, and expressed as the percentage of input pep- 
tide. The size of the respective  input peptides  is indicated  on the horizontal 
axis. The peptides are, respectively,  #49, #50, #53, #54, SN12, SN12A1, 
#55, SN11, #88, #89, and #90 (top) and #146, #147, #148, #149 and #150 
(bottom). For sequence, see Materials and Methods. 
containing the N-linked glycosylation consensus sequence 
(Asn-X-Thr/Ser) were added to streptolysin O permeabilized 
cells in the presence of ATE Translocation of such peptides 
into the EK results in the addition of a N-linked glycan. The 
resulting  glycosylated peptide  can  be  isolated  with  Con 
A-Sepharose  beads and further analyzed. We used the mu- 
tant cell line T2 that has a deletion of the TAP genes,  and 
compared them with T2 ceils reconstituted with cDNAs en- 
coding rat TAP1 and TAP2 a (T2/TAPI+2) (24). Thus, any 
difference in the recovery of translocated peptides in T2 and 
T2/TAP1 + 2 cells can only be due to expression of TAP1 and 
TAP2 ~. 
A number of model peptides of different size and sequence 
were synthesized (cf. Materials and Methods) and radioiodi- 
nated. The amount of translocated peptide was determined 
by "r counting (Fig.  1). Whereas none of the peptides was 
translocated in streptolysin O-permeabilized T2 cells, pep- 
tide translocation was observed in permeabilized T2/TAP1 + 2 
cells for all peptides except  the 4 and 5 mer.  We conclude 
that TAP does not select peptides with a size below six amino 
acids. 
The Relative Aj~nity of Different Peptide Lengths for TAP. 
The outcome of the translocation experiment shown in Fig. 
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Figure 2.  Competition  for translocation  of  a 9-mer model  peptide  with 
peptides of different  length. The iodinated  9-mer peptide #147 (sequence 
TVDNKTRAY) was translocated  for 5 min in washed  streptolysin  O-per- 
meabilized T2/TAPI+  2 cells in the presence of different  concentrations 
of competitor peptides of different  size. The glycosylated  peptides were 
recovered by Con A-Sepharose and quantitated. The 9- and 11-met pep- 
tide competed  most  efficiently.  Longer  peptides  as well  as smaller  peptides 
competed less efficiently  for translocation of the 9-mer input peptide. 
1 is influenced by the relative affinity of the peptides for TAP, 
the transit time, and their stability in the cytosol and the 
ER. To determine the relative affinities for TAP of peptides 
of different length, T2/TAPI+2 ceils were permeabilized, 
the cytosol was removed by washing, and translocation of 
the 9-mer peptide #147 (sequence TVDNKTKAY) was in- 
hibited with unlabeled peptides of different size but similar 
sequence (see Materials and Methods). To reduce any effect 
of proteolysis of the input and competitor peptides,  the trans- 
location assay was performed for only 5 min. The translo- 
cated peptides were recovered  with Con A-Sepharose and 
quantitated (Fig.  2).  The 9- and ll-mer peptide competed 
most efficiently (50%  inhibition at "~2 #M).  50% inhibi- 
tion for translocation with the 8-mer peptide #53 was found 
at '~10 #M and for the 10-mer peptide #55 between 1 and 
5 #M (not shown). With increasing length, the peptides in- 
hibited less efficiently with the exception that the 15 mer 
competed somewhat better than the 13-mer peptide. The 20- 
mer peptide competed ~,,50 times less well than the 9 and 
11 mer, and the 40 mer was an even poorer competitor. Also, 
the 7-mer peptide #146 competed very inefficiently, although 
a small amount of the 7-mer peptide was actually translo- 
cated, as indicated by the experiments in which directly la- 
beled peptide was used (Fig.  1 B). Thus, peptides with an 
optimal length for binding to class I molecules (8-11  amino 
acids) inhibited TAP-dependent transport most effectively, 
suggesting that these peptides bound TAP with the highest 
affinities. 
Translocation of Degradation Intermediates.  The observations 
that  radiolabeled  glycopeptides  were  isolated  with  Con 
A-Sepharose after TAP-dependent translocation of a 20- or 
40-mer iodinated peptide (Fig. 1) and that these peptides have 
a low affinity for TAP (Fig. 2) did not exclude that the 20- 
or 40-met peptides were proteolytically truncated before being 
1615  Momburg  et al. Figure 3.  Peptide size selection by TAP. (A) Kinetics of translocation of the 11-mer peptide SNll and the 16 (#88), 20- (#89) and 40-met (#90) 
derivatives from SN11 generated by a NH/-terminal repeat of S and G residues, as indicated above the figure. The corresponding experiments  shown 
in Fig. 3  (B-D)  are placed below the respective figures. The peptides were translocated for different periods in streptolysin O-permeabilized T2/ 
TAP1+ 2 cells in the presence of ATP. As a control, the 16-met peptide was translocated in the absence of ATP (closed  symbols). At the respective time 
points,  cells were lysed and the translocated peptides were isolated with Con A-Sepharose. For all four peptides, transport  is rapid within the first 
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tion in the cytosol in our experiments,  we simultaneously 
measured translocation and degradation of the 11-mer model 
peptide RYWANATRSGG and the same peptide elongated 
at  the NH2 terminus  by a repeat  of S and G  to a  16,  20, 
and 40 mer, respectively. The peptides were iodinated and 
the kinetics of translocation was determined (Fig. 3 A; the 
sequence of the peptides is shown on top). The highest rates 
of translocation were observed during the first 10-20 min. 
Note that  translocation  again was most efficient with  the 
16-mer peptide and least e~cient with the 40-mer peptide 
(cf.  Fig.  1). 
To follow the fate of the input peptide, an aliquot of the 
reaction mixture (containing permeabilized cells, ATP,  and 
input  peptide) was taken at  each time point  and analyzed 
by TIC (Fig. 3 B). The closed triangles show the position 
of the input peptide and the open triangles show the posi- 
tion of the major breakdown product, which is most prob- 
ably iodotyrosine. The rate of degradation of the input pep- 
tide was inversely correlated with the length of the peptide: 
the 11-mer peptide was degraded rapidly and the 40-met pep- 
tide slowly. 
Next we analyzed the glycosylated (and thus translocated) 
peptide on TLC (Fig.  3 C). The positions of the different 
input peptides are indicated by their size. The glycosylated 
peptides migrated as a smear on TLC (lanes '"') because of 
the heterogeneity of glycosylation. The N-linked glycan (ex- 
cept for the inner GlcNAc) was removed with Endo H  and 
the deglycosylated peptides were again analyzed (lanes Endo 
H). Iodinated peptides migrating  at a similar position were 
observed after translocation of all the four different input pep- 
tides. This position corresponded to a migration between the 
11- and the 16-met input peptides which were run as stan- 
dards.  Since TIC mainly separates  according to hydropho- 
bicity but not by size, this did not imply that the transported, 
deglycosylated peptide had a length somewhere between 11 
and  16 amino  acids.  However, the fact that  the input  and 
the translocated peptide migrated at a different position on 
TIC suggested that TAP selects for peptides of a defined length 
that can be generated by degradation of longer peptides. The 
glycosylated peptides were also analyzed by Tricine SDS-PAGE, 
which allows separation of small molecules mainly according 
to size (Fig. 3 D). The position of the 20- and 40-mer input 
peptide is indicated. A band migrating approximately at the 
position of the 40-met input peptide with an approximate 
molecular weight of ~3.4 kD is observed for the 11-,  16-, 
and 20-met input peptide (we did not recover enough trans- 
located 40-mer peptide to allow visualization). The N-linked 
glycan has a molecular mass of ~2.4 kD. Thus,  the molec- 
ular mass of the peptide core can be estimated to ,,ol kD, 
corresponding to about 9-11 amino acids. Our data suggest 
that the translocated peptides have a similar molecular weight 
for the three input  peptides,  implying that  short peptides 
of defined size are selected by TAP. 
Peptides Containing an N-linked Glycan Are Stable in the ER. 
Peptide translocation approached a steady state after some 20 
rain (reference 16; Fig. 3 A). If this was only caused by shortage 
of the input peptide due to degradation,  this would imply 
that the translocated and thus glycosylated peptide is stable 
in the ER. To examine the stability of glycosylated peptides 
in  the  ER,  further  import  of peptides  was  inhibited  by 
depleting ATP with hexokinase (HK) and glucose. This treat- 
ment resulted in almost complete inhibition (~>85%) of pep- 
tide translocation within 10 min (Fig.  4 A). To address the 
question of glycopeptide stability in the ER, peptide trans- 
location in T2/TAP-I+ 2 was allowed to proceed for 10 min 
in the presence of ATP. Thereafter ATP was depleted (or not) 
with HK and glucose and the cells were further incubated 
at 37~  for various times. Translocation was not complete 
after 10 rain because undepleted cells consistently contained 
targer  amounts of glycosylated peptide than  ATP-depleted 
samples (Fig.  4 B). Furthermore,  there was no decrease in 
the amount of recovered glycopeptide for as long as 80 min 
after ATP depletion.  This indicated  that  the peptide,  once 
imported in the ER and glycosylated, remained  stable.  To 
show that the peptides were indeed not further modified in 
the ER, we analyzed the Con A-isolated peptides after Endo 
H treatment by TLC (Fig. 4 B). The peptides isolated at the 
different time points  migrated  at  identical  positions,  con- 
firming that  the peptides were not further modified in the 
ER. This was true for all of the four peptides studied (#72, 
#88,  #78,  and SN12A1). 
The Size of the Translocated Peptides.  The translocated pep- 
tides analyzed in Fig. 4 B were further characterized by es- 
tablishing the position of the iodotyrosine (Y). This was done 
by determining the number of Edman degradation steps re- 
quired to release  the iodine label (Fig.  5 A).  This allowed 
us to determine the number of amino acids located on the 
NH2-terminal side of the iodinated Tyr (Y) but did not pro- 
vide information  on the exact location of the COOH  ter- 
minus with the peptides used here.  Using radiolabeled pep- 
tide #72 (sequence RYWANATRSY) in a translocation assay, 
two major transported glycopeptides were recovered (Fig.  4 
B), which were extracted separately from TLC plates and sub- 
jected to Edman degradation.  This showed the upper band 
on the chromatogram to contain a peptide with Tyr at posi- 
10 min and then levels off. No peptide translocation is observed  in the absence of ATP. (/3) Degradation of the input peptides. Samples were taken 
from the reaction mixture at the time points indicated above the figure and analyzed on TIC. (Closed arrowhead) The position of the input peptide; 
(open arrowhead) the position of the major breakdown product. The input 11-mer peptide is degraded very rapidly, the 16- and 20-mer peptides are 
degraded after some 20 min, and the input 40-mer peptide is degraded slowly. (C) TLC analysis of the translocated peptides. The glycosylated  peptides, 
quantitated in Fig. 3 A, are released from Con A-Sepharose after transport for the indicated periods and analyzed  by TLC either untreated (lanes "-") 
or after Endo H treatment (lanes Endo H). The positions of the 11-, 16-, 20-, and 40-mer input peptide are indicated. Whereas the glycosylated  peptides 
migrated as a smear on TIC plates, after deglycosylation  with Endo H the translocated peptides derived from the 11, 16, 20, and 40 mer all migrated 
at a similar position intermediate between the 11- and 16-mer input peptides used as marker. (D) Analysis of the translocated peptides by Tficine SDS- 
PAGE. The translocated peptides were released from Con A-Sepharose and analyzed by Tricine SDS-PAGE. The translocated peptides migrate at the 
position of the (unglycosylated)  40-met input peptide used as size standard along with the 20 met. 
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Figure 4.  Glycosylated peptides are stable in the ER.  (A) Inhibition 
of peptide translocation by depletion of ATP with HK and glucose. To 
determine the effaciency  of inhibition of peptide translocation by deple- 
tion of ATE peptide #72 (sequence RYWANATRSY) was added to strep- 
tolysin O-permeabilized  T2/TAPI+2 cells for 10 rain either in the pres- 
ence of ATP alone (bar no HK), or after different periods of pre-incubation 
with ATE HK, and glc, as indicated. Translocated peptides were isolated 
with Con A-Sepharose and quantitated.  Pre-incubation for 10 min with 
HK/glc significantly inhibited ATP-dependent peptide translocation. (B) 
The stability of translocated peptides. Peptides #72, #88, SN12A1, or #78 
(sequence indicated  above  the figure) were translocated  in streptolysin  O-per- 
meabilized T2/TAP1 + 2 cells either in the presence (closed  squares) or ab- 
sence (closed triangles) of ATP (top). In parallel samples, ATP was depleted 
by addition of HK/glc after a 10-min translocation in the presence of ATP 
(open circles). Cells were lysed after different periods and the translocated 
peptides were recovered with Con A-Sepharose. Peptide translocation was 
ATP dependent and depletion of 
ATP  resulted  in  a  decreased 
recovery of translocated peptides. 
The iodotyrosine  label was not re- 
moved from the translocated pep- 
tides. The translocated peptides 
were  further  analyzed by TLC 
after  removal of  the  N-linked 
glycan  with Endo H (bottom). The 
input peptide is shown for com- 
parison. No detectable modificat- 
ions of the  translocated peptide 
were observed by TLC indicating 
that the glycosylated peptides re- 
mained stable in the  ER.  Note 
that input peptide #72 appeared 
as two distinct species in the ER. 
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Figure 5.  Sequence  analysis of the translocated peptides. 
(A) Analysis of the translocated peptides #72, SN12A, #78, 
and #88, shown in Fig. 4 B. The peptides were isolated 
from the TLC plate and the number of Edman degrada- 
tion steps required to release the label (corresponding to 
iodotyrosine [Y]) was determined. The number of Edman 
degradation steps is indicated on the x-axis and the amount 
of radioactivity released in every step on the y-axis. The 
predicted sequence is shown. The upper band of the dou- 
blet observed after translocation of peptide #72 starts with 
Y at position 2 of the input peptide (#72-1),  and the lower 
band at R at position I of the input peptide (#72-2). The 
translocated peptide derived from the 16-mer peptide #88 
starts with S, R, or Y at, respectively, position 5, 6, or 
7 of the peptide. The predominant peptide recovered after 
translocation of input peptide #78 starts with T at posi- 
tion 2. Translocated peptide SN12A1 starts with A at po- 
sition 1, like the input peptide. (B) Size of the translo- 
cated  peptides.  The  peptides  #147 (9  mer;  sequence 
TVDNKTRAY),  #148 (11 mer; sequence  ETVDNKT- 
FRAY), and #149 (13 met; sequence IETVDNKTSFRAY) 
were added to streptolysin O-permeabilized T2/TAPI+ 2 
or LCL 721 cells (as indicated) and the translocated pep- 
tides were recovered with Con A-Sepharose.  Because the 
peptides contain a COOH-terminal radioiodinated Y res- 
idue,  the number of Edman degradation steps required 
to release the label is directly correlated to the length of 
the translocated peptide. The number of Edman degrada- 
tion steps  is indicated on the x-axis; the radioactivity 
released in the respective cycles on the y-axis. The rat and 
human peptide transporters translocate peptides with a 
size of 7-13 amino acids. 
tion  1,  whereas  the  lower band had  Tyr at position  2  and 
presumably  was  unmodified  at  the  NH2  terminus  (Fig.  5 
A). By a similar analysis, the translocated glycopeptide spe- 
cies derived  from  peptide  #88  ([GS]2SRYWANATRSGG) 
contained  Tyr mainly at position  1  to 3.  The SN12A1  (se- 
quence AYWANATRSG)  derived translocation product con- 
tained Tyr at position 2, whereas most of the product of the 
11-mer peptide #78  (sequence KTWANATRSYE)  had Tyr 
at position 9  (Fig.  5 A).  The latter peptide could not  have 
been  shortened  at the  COOH  terminus by more  than  one 
amino  acid. 
To establish the exact size of the translocated peptides, the 
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9-mer peptide #147,  the  ll-mer  peptide #148,  and  the  13- 
mer peptide #149, all containing a COOH-terminal  Y, were 
translocated in T2/TAP1 + 2 ~ cells and the number of Edman 
degradation  steps required  to release the  iodine label (now 
corresponding  to the COOH-terminal  amino acid) was de- 
termined  (Fig. 5 B).  The peptide #147 was mainly translo- 
cated as a 9-mer, but also 8- and 7-mer peptides were recov- 
ered from the ER.  Mainly a  10- and a  ll-mer  peptide were 
translocated after addition ofpeptide #148, but minor amounts 
of smaller degradation  products  were  also found.  Peptides 
ranging from 9 to 13 amino acids derived from peptide #149 
were translocated.  To establish whether  the human  peptide cpm 
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Figure 6.  Peptide  degradation  in the ER. (A) Stability  of  unglycosylated 
peptide #88 (sequence GSGSSRYWANATRSGG)  in the ER. N-linked 
glycosylation  was inhibited with tunicamycin  and peptide #88 was trans- 
located in streptolysin  O-permeabilized  T2 (open triangles) or T2/TAPI+ 2 
(open circles) cells for different periods in the presence of ATP. Alterna- 
tively, further peptide translocation  was inhibited after 10 rain by addition 
of HK and glc to permeabilized  T2/TAP1 + 2 cells (closed  squares). At the 
respective time points, cells were transferred to 0~  washed extensively, 
and the amount of radioactivity retained was quantitated. Peptide #88 is 
efficiently  translocated  by TAP during the first 10 rain, followed  by release 
of the translocated peptides after 20 min. (B) Degradation of the input 
peptide #88. Like Fig. 3 B, samples of the input peptide were analyzed 
by TLC after different  periods of incubation with strepto|ysin O-permea- 
bilized T2 or T2/TAPI+2 cells, as indicated. The input peptide #88 is 
rapidly  degraded  at similar rates in T2 and T2/TAPI+ 2 cells. (C) Analysis 
of the translocated peptides by TLC. The cells containing the associated 
peptide, as quantitated  in A, were extracted  with phenol, analyzed  by TIC, 
and the radiolabeled  peptide was detected  by autoradiography.  The corre- 
sponding time points and conditions are indicated. A number of peptides 
were exclusively  retained in T2/TAPI+ 2 cells. Their appearance  follows 
the kinetics shown in A, and they migrate differently  from the input pep- 
tide #88 and the major degradation product (Fig. 6 B). ATP depletion 
with HK and glc does not inhibit peptide release. Note the minor radiola- 
beled species associated with T2/TAPI+2 cells. 
transporter  selects  for peptides  in  a  similar  fashion  as  rat 
TAPI+2L the 13-mer peptide #149 was also translocated in 
streptolysin O-permeabilized LCL 721 cells (Fig. 5 B, #149 
LCL  721).  The peptides derived from peptide #149 contained 
10-13  amino  acids  as concluded from the Edman degrada- 
tion of the  transported  peptide mixture  in LCL 721. 
Non-glycosylated  Peptides Are Unstable in the ER.  Glycosy- 
lated peptides are stable in the ER (see Fig. 4 B).  This may 
be due either to the absence of proteolytic activity in the ER., 
or to protection by the N-linked glycan against  proteolysis 
or re-export. We studied the fate of the translocated peptide 
#88  in  T2  and  T2/TAPI+2  cells  that  were  treated  with 
tunicamycin to inhibit N-linked glycosylation. Since now the 
translocated peptide could not be recovered by Con A-Sepha- 
rose through its N-linked glycan, peptide translocation was 
followed by extensive washing of the streptolysin O-permea- 
bilized cells. Peptides in the intact ER will be protected against 
removal by washing. After washing, the cells were extracted 
with  phenol  to denature  all proteins  and  the radioactivity 
recovered in  the phenol  phase  was  quantitated  (Fig.  6 A). 
We determined beforehand that the majority (•80-90%)  of 
input  peptide will partition into the phenol phase.  Again, 
any  difference between  T2  and  T2/TAPI+2  cells  in  the 
amount  of radioiodinated  peptide retained can  only be at- 
tributed to TAP, which will translocate the peptides into the 
ER. In T2 cells, similar amounts of background radioactivity 
were recovered at each time point. Expression of TAP resulted 
in a rapid increase in the amount of radioactivity recovered 
during the first 10 min,  similar to the increase observed for 
cells that were not treated with tunicamycin (cf. Figs.  3 A 
and 4/3).  However,  this  initial increase was  now followed 
by a rapid  drop in radioactivity resistant  to washing,  sug- 
gesting rapid release of the peptide  (or fragments  thereof) 
from  the ER.  Also,  inhibition  of further  translocation by 
enzymatic depletion of ATP after translocation for 10 min 
resulted in a rapid decrease in the amount of nonglycosylated 
peptide retained in cells  (Fig.  6  A), 
We then analyzed the fate of the input peptide (Fig. 6 B) 
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peptide was rapidly and in a similar fashion degraded in both 
T2 and T2/TAPI+ 2 cells (see also Fig. 3 B). The breakdown 
intermediates were not identified. After extensive washing, 
a background band was still  associated  with permeabilized 
T2 cells (Fig.  6 C). However, a number of bands retained 
in permeabilized T2/TAPI+ 2 cells after extensive washing 
appeared during the first 10 rain and disappeared at later time 
points. Note the appearance of minor radiolabeled degrada- 
tion species.  Addition of HK and glucose (glc) after a 10- 
min translocation of peptide #88 also showed a clear decrease 
in the amount of isolated peptide. The half-life of the non- 
glycosylated peptide fragment #88 in the ER can be estimated 
to be ,,o20 min. 
Discussion 
MHC class I molecules present peptides that are derived 
from nuclear or cytosolic antigens to CD8 + T  cells.  The 
resolution of the three-dimensional structure of class I mole- 
cules associated with peptide showed that the peptide is deeply 
embedded in the binding groove (31, 32), explaining the ob- 
servation that peptide is essential for the stability of class I 
molecules (3). These nuclear/cytosolic peptides are trapped 
by class  I  H  chain/~2-microglobulin heterodimers in  the 
lumen of the Elk (3, 4, 6) which is preceded by translocation 
of the peptides from the cytosol to the lumen of the ER by 
the  TAP  heterodimer (16,  26,  27).  TAP  shows  substrate 
specificity (33)  and selects peptides with proper NH2- and 
COOH-terminal residues (34,  35).  However, it is still un- 
clear how antigenic peptides are generated, in what form they 
are translocated and what their fate is in the lumen of the Elk. 
We show that intact 16-mer or longer model peptides were 
not or were inefficiently translocated by TAP.  Instead, we 
found translocated peptides derived from the 16-mer input 
peptide #88 that contained 12 or fewer amino acids. This in- 
dicates that TAP selects for the size of the peptide. The upper 
limit is not exactly defined here but we show that a 13-mer 
model peptide (#149) was translocated without modifications, 
whereas the 16-mer (#88) peptide required prior trimming. 
It was recently shown that TAP-dependent peptide translo- 
cation can be inhibited by peptides of different length (16, 
31,  32), but these studies were not fully conclusive.  Since 
the fate of the input peptide was not followed, it was unclear 
whether competition was due to the input peptide or a degra- 
dation fragment thereof. Furthermore, since competition for 
translocation does not imply that the competitor is translo- 
cated, the actual size of the translocated peptides could not 
be established in these studies. 
We determined the size  of the translocated peptide by 
Edman degradation. The smallest peptides we found trans- 
located contain 6-7  amino acids whereas the longest con- 
tained 13 amino acids.  Since peptides of 7 or 12-13  amino 
acids  are unlikely to associate  with class I molecules with 
high affinity (although there may be exceptions), this indi- 
cates that the size selection by TAP does not accurately meet 
the requirements for optimal binding to class I molecules. 
Nevertheless, it is striking that the size range of peptides found 
associated  with class I molecules (8-11  amino acids;  refer- 
ence 1) is covered by the size of peptides selected by TAP. 
However, longer peptides do compete for translocation of 
a 9-met model peptide but the relative affinity decreases with 
size. Probably, peptides longer than 13 amino acids can be 
translocated, but with lower efficiency. As a result, these longer 
peptides will rather be degraded in the cytosol and their degra- 
dation intermediates of optimal size (8-11 amino adds) will 
be preferably selected by TAP because these intermediates have 
the highest (relative)  affinity for TAP (see Fig.  3).  This, as 
we show, does not exclude the possibility that shorter or longer 
peptides enter the ER. Furthermore, the amount of peptides 
that ultimately enter the ER will be determined by the se- 
quence as well as the relative concentration of these peptides 
in the cytosol. Other peptide transporters with ATP-binding 
cassettes have been described but their size selection is different. 
The yeast protein STE6 transports a lipid-modified 12-met 
peptide, the a-factor, across the plasma membrane (36). The 
bacterial oligopeptide permease Opp, however, transports pep- 
tides of up to five amino acids in length (37). 
In the lumen of the ER,  MHC class I heterodimers as- 
sociate with peptides of 8-11 amino acids (1). Since slightly 
longer peptides apparently can be translocated, these peptides 
might require trimming before being able to bind tightly 
to class I molecules. In the assay used in this study, we fol- 
lowed N-linked glycosylation of peptides as a marker for ap- 
pearance in the lumen of the ER. We show that the N-linked 
glycan protects peptide against degradation in the ER. How- 
ever, most  naturally occurring peptides  do not  obtain  an 
N-linked glycan in the EIk and we show that these peptides 
are rapidly degraded and released from the ER. The suhstrate 
specificity of this peptide export mechanism is unknown and 
their prime function may be to remove signal sequence frag- 
ments and peptides that do not associate with class I mole- 
cules, from the ER lumen. Thus, class I molecules, the EK- 
degradation machinery, and the mechanism that releases pep- 
tides from the EIk, compete for peptides in the Elk. If a pep- 
tide fails to bind to class I molecules, it will be rapidly ex- 
ported from the ER and degraded outside. This explains why 
Falk et al.  (38) were unable to detect a peptide fraction in 
cells other than the class I-bound peptides. Due to rapid degra- 
dation, a stable pool of peptides is apparently not available 
in the Elk or the cytosol. However, Elk-located accessory mol- 
ecules, like BiP (39) and grp94 (40), may bind some peptide 
and thereby protect them against further degradation in the 
ER and thus serve as a peptide reservoir. Whether these mol- 
ecules are involved in the loading of class I molecules with 
peptide remains to be established. 
We have followed the early processes  involved in MHC 
class I-restricted antigen presentation using streptolysin O-per- 
meabilized cells.  We show that input peptides are rapidly 
degraded and that TAP concomitantly selects for peptide frag- 
ments with a size range that covers the length of peptides 
associated with class I molecules. Peptides that do not bind 
to class I molecules are rapidly released from the Elk. 
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